Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep:102:101274.
doi: 10.1016/j.preteyeres.2024.101274. Epub 2024 May 28.

Pseudoxanthoma elasticum - Genetics, pathophysiology, and clinical presentation

Kristina Pfau  1 , Imre Lengyel  2 , Jeannette Ossewaarde-van Norel  3 , Redmer van Leeuwen  3 , Sara Risseeuw  3 , Georges Leftheriotis  4 , Hendrik P N Scholl  5 , Nicolas Feltgen  6 , Frank G Holz  7 , Maximilian Pfau  8
Affiliations
Free article
Review

Pseudoxanthoma elasticum - Genetics, pathophysiology, and clinical presentation

Kristina Pfau et al. Prog Retin Eye Res. 2024 Sep.
Free article

Abstract

Pseudoxanthoma elasticum (PXE) is an autosomal-recessively inherited multisystem disease. Mutations in the ABCC6-gene are causative, coding for a transmembrane transporter mainly expressed in hepatocytes, which promotes the efflux of adenosine triphosphate (ATP). This results in low levels of plasma inorganic pyrophosphate (PPi), a critical anti-mineralization factor. The clinical phenotype of PXE is characterized by the effects of elastic fiber calcification in the skin, the cardiovascular system, and the eyes. In the eyes, calcification of Bruch's membrane results in clinically visible lesions, including peau d'orange, angioid streaks, and comet tail lesions. Frequently, patients must be treated for secondary macular neovascularization. No effective therapy is available for treating the cause of PXE, but several promising approaches are emerging. Finding appropriate outcome measures remains a significant challenge for clinical trials in this slowly progressive disease. This review article provides an in-depth summary of the current understanding of PXE and its multi-systemic manifestations. The article offers a detailed overview of the ocular manifestations, including their morphological and functional consequences, as well as potential complications. Lastly, previous and future clinical trials of causative treatments for PXE are discussed.

Keywords: ABCC6; Bruch's membrane; PXE; Pseudoxanthoma elasticum.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

MeSH terms

Substances

LinkOut - more resources